Individuals who suffer from symptoms of gastrointestinal, autoimmune, dermatological and pain conditions make up 80% of the patient population. The good news? Low-dose naltrexone (LDN) has been studied recently in many conditions. This presentation will provide insight into the science, physiology and mechanisms of action of LDN, and answer your questions about the many conditions it may be beneficial for, including:
• COVID long-haul
• Crohn’s disease
• Ulcerative colitis
• IBS
• Migraines
• Arthritis
• Fibromyalgia
• Pain
• PTSD/anxiety
• Multiple sclerosis
• Inflammatory conditions of the skin
• Hashimoto’s thyroiditis
• And more
A live Q